HEALTH● LOWAug 31 · Aug 31, 2026, 9:07 AM
Amgen's Repatha cuts death risk by 20% in heart study
Seeking Alpha Tech · global
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH25m agoRoche's Enspryng wins FDA approval for thyroid eye diseaseSeeking Alpha TechHEALTH1h agoHome-bound elderly care lays thrust on home-based comprehensive assessmentThe HinduHEALTH2h agoStates Pledge Meta $17 Billion Teen Social Media Settlement to Youth Mental Health , but Few Rules Bind Spendingmedicaldaily.com · United StatesHEALTH2h ago10 , 329 Oxfordshire patients faced ambulance delays in yearwitneygazette.co.uk · United Kingdom